These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7787987)

  • 1. Small hepatocellular carcinoma: its relationship to multistep hepatocarcinogenesis.
    Uchida T
    Pathol Int; 1995 Mar; 45(3):175-84. PubMed ID: 7787987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of multistep hepatocarcinogenesis: genetic and epigenetic events.
    Hui AM; Makuuchi M
    Scand J Gastroenterol; 1999 Aug; 34(8):737-42. PubMed ID: 10499472
    [No Abstract]   [Full Text] [Related]  

  • 4. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
    Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of epigenetic aberrations in the development of hepatocellular carcinoma.
    Zhang Y
    Methods Mol Biol; 2015; 1238():709-31. PubMed ID: 25421688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma in the non-cirrhotic liver].
    Evert M; Dombrowski F
    Pathologe; 2008 Feb; 29(1):47-52. PubMed ID: 18057936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
    Piao Z; Kim H; Jeon BK; Lee WJ; Park C
    Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology and molecular mechanisms of multistage human hepatocarcinogenesis.
    Hirohashi S
    Princess Takamatsu Symp; 1991; 22():87-93. PubMed ID: 1726934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with the use of sex hormones.
    Taylor W
    Anticancer Res; 1987; 7(5B):943-8. PubMed ID: 2829703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of a newly recognized protein, LECT2, in hepatocellular carcinoma and its premalignant lesion.
    Uchida T; Nagai H; Gotoh K; Kanagawa H; Kouyama H; Kawanishi T; Mima S; Yamagoe S; Suzuki K
    Pathol Int; 1999 Feb; 49(2):147-51. PubMed ID: 10355968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice.
    Pasquinelli C; Bhavani K; Chisari FV
    Cancer Res; 1992 May; 52(10):2823-9. PubMed ID: 1316229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
    Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
    J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.
    Itoh T; Shiro T; Seki T; Nakagawa T; Wakabayashi M; Inoue K; Okamura A
    Int J Mol Med; 2000 Aug; 6(2):137-42. PubMed ID: 10891556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics of surgically resected minute hepatocellular carcinomas.
    Maeda T; Takenaka K; Taguchi K; Kajiyama K; Shirabe K; Shimada M; Tsuneyoshi M; Sugimachi K
    Hepatogastroenterology; 2000; 47(32):498-503. PubMed ID: 10791221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma associated with recreational anabolic steroid use.
    Gorayski P; Thompson CH; Subhash HS; Thomas AC
    Br J Sports Med; 2008 Jan; 42(1):74-5; discussion 75. PubMed ID: 18178686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.
    Osada T; Sakamoto M; Nishibori H; Iwaya K; Matsuno Y; Muto T; Hirohashi S
    J Hepatol; 1997 Jun; 26(6):1266-73. PubMed ID: 9210613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing Borderline Hepatic Nodules in Hepatocarcinogenesis: Imaging Performance.
    Choi BI; Lee JM; Kim TK; Dioguardi Burgio M; Vilgrain V
    AJR Am J Roentgenol; 2015 Jul; 205(1):10-21. PubMed ID: 26102378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.